Home/Filings/4/0001209191-18-058330
4//SEC Filing

Presnell Sharon Collins 4

Accession 0001209191-18-058330

CIK 0001497253other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 5:17 PM ET

Size

5.1 KB

Accession

0001209191-18-058330

Insider Transaction Report

Form 4
Period: 2018-11-08
Presnell Sharon Collins
EVP, Research & Development
Transactions
  • Sale

    Common Stock

    2018-11-08$1.27/sh40,000$50,800292,193 total
Footnotes (2)
  • [F1]The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]This number does not include 2,257,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell beneficially owns or has a right to acquire 2,549,385 shares of common stock.

Issuer

ORGANOVO HOLDINGS, INC.

CIK 0001497253

Entity typeother

Related Parties

1
  • filerCIK 0001536585

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 5:17 PM ET
Size
5.1 KB